Home・Список акций・Certara Inc

Certara Inc

Закрыт

СекторЗдравоохранение

8.07 -1.22

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

7.99

Макс.

8.18

Ключевые показатели
By Trading Economics
Доход	-2.9M -8.8M
Продажи	3.3M 107M
P/E Средняя по отрасли	100.714 68.51
Прибыль на акцию	0.09
Рентабельность продаж	-8.196
Сотрудники	1,515
EBITDA	-16M 16M

Рекомендации
By TipRanks
Рекомендации	Покупка
Прогноз на 12 месяцев	+1.73% upside

Дивиденды
By Acuity
Следующий отчет о доходах	5 нояб. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	474M 1.3B
Предыдущая цена открытия	9.29
Предыдущая цена закрытия	8.07

Новостные настроения

By Acuity

50%

128 / 340 Рейтинг в Healthcare

Certara Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

7 авг. 2026 г., 19:26 UTC

Certara Inc shares are higher today, maintaining a positive trajectory since Thursday. The stock remains above its 20-day moving average.

6 авг. 2026 г., 20:02 UTC

News

Certara Inc is rising today, driven by strength in the Health Care Technology sub-sector. The stock remains above its 20-day moving average.

5 авг. 2026 г., 20:13 UTC

Certara Inc shares are lower in after-market trading amid broader market fluctuations and rising gold prices, reflecting ongoing geopolitical tensions.

4 авг. 2026 г., 20:03 UTC

News

Certara reported a second-quarter net loss of $6.1 million and lowered its full-year guidance, contributing to a decline in shares during today's session.

3 авг. 2026 г., 19:26 UTC

News

Certara Inc shares are higher, supported by gains in the Health Care Technology sector. The company will report Q2 2026 results on August 4.

31 июл. 2026 г., 19:26 UTC

Certara Inc shares are higher today, recovering from an early dip and trading near the top of their one-month range. No specific news was identified.

30 июл. 2026 г., 19:58 UTC

Certara Inc is lower amid Health Care Technology sub-sector weakness. The stock reversed an early gain and remains above its 20-day moving average.

29 июл. 2026 г., 18:53 UTC

Health Care Technology sector strength is lifting Certara Inc during Wednesday's session. The asset remains above its 20-day moving average, marking six straight days of gains.

28 июл. 2026 г., 18:36 UTC

Certara Inc is higher during Tuesday's session, continuing gains from Monday. The stock remains above its 20-day moving average despite an intraday pullback.

27 июл. 2026 г., 19:07 UTC

Certara Inc shares are trading higher during Monday's session, reflecting positive momentum since Friday's close, despite no specific company news identified.

24 июл. 2026 г., 18:02 UTC

Certara Inc shares are trading higher today, continuing gains since Thursday's close. No specific news was identified to explain the upward movement.

23 июл. 2026 г., 20:06 UTC

Shares of Certara Inc are higher during Thursday's session, continuing a notable increase since Wednesday's close. No specific news was identified for this movement.

22 июл. 2026 г., 20:04 UTC

Certara Inc's shares are higher during Wednesday's session, recovering from an early decline amid broader market uncertainty ahead of the Federal Reserve meeting.

20 июл. 2026 г., 19:31 UTC

News

Certara Inc partners with NVIDIA to enhance its AI biosimulation platform. Shares are higher, reflecting positive market sentiment around the collaboration.

Сравнение c конкурентами

Изменение цены

Certara Inc Прогноз

Целевая цена

By TipRanks

1.73% рост

Прогноз на 12 месяцев

Средняя 8.21 USD 1.73%

Максимум 9 USD

Минимум 7 USD

Основано на мнении 9 аналитиков Wall Street, спрогнозировавших целевые цены для Certara Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

9 ratings

Покупка

Удержание

Продажа

Основано на мнении 9 аналитиков, присваивавших рейтинги акциям Certara Inc – Данные за последние 3 месяца.

Настроения

By Acuity

128 / 340Рейтинг в Здравоохранение

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Certara Inc

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.